A biotechnological product and its potential as a new immunomodulator for treatment of animal phlebovirus infection: Punta Toro virus

Antiviral Research

Volumn 83, Issue 2, 2009, Pages 143-147

  Durán, Nelson ^a,b   Gowen, Brian B ^c   Costa, Fabio T M ^a   Justo, Giselle Z ^d   Brocchi, Marcelo ^a   Nunes, Odilon S ^b   Nunes, Iseu S ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Farmabrasilis R and D Division   (Brazil)

^c UTAH STATE UNIVERSITY   (United States)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Immunomodulator; P MAPA; Punta Toro virus; Virus

Indexed keywords

ALANINE AMINOTRANSFERASE; IMMUNOMODULATING AGENT; MAGNESIUM AMMONIUM PHOSPHOLINOLEATE PALMITOLEATE ANHYDRIDE; PLACEBO; RIBAVIRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS ORYZAE; BIOTECHNOLOGY; CONTROLLED STUDY; DEATH; DISEASE MODEL; DRUG EFFICACY; DRUG RESEARCH; FEMALE; IMMUNOMODULATION; IMMUNOTHERAPY; LIVER DISEASE; MOUSE; NONHUMAN; PHLEBOVIRUS; PRIORITY JOURNAL; PUNTA TORO VIRUS; SINGLE DRUG DOSE; TREATMENT OUTCOME; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS LOAD;

ANIMALS; ANTIVIRAL AGENTS; ASPERGILLUS ORYZAE; BUNYAVIRIDAE INFECTIONS; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INJECTIONS, INTRAPERITONEAL; LIVER; MICE; PHLEBOVIRUS; SURVIVAL ANALYSIS;

ANIMALIA; ASPERGILLUS ORYZAE; PHLEBOVIRUS; PUNTA TORO VIRUS;

EID: 67449126846     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.04.006     Document Type: Article

References (43)

1. Ampligen, 2008. Hemispherx Biopharma. Retrieved on April 26, 2008.
2. Anderson Jr. G.W., Slayter M.V., Hall W., and Peters C.J. Pathogenesis of a phleboviral infection (Punta Toro virus) in golden Syrian hamsters. Arch. Virol. 114 (1990) 203-212
3. Bromberg N., Justo G.J., Seabra A.B., and Durán N. Macrophage nitric oxide (NO) stimulation by an immunomodulator: P-MAPA. Nitric Oxide-Biol. Chem. 14 (2006) A37
4. Colic M., Gasic S., Vucevic D., Pavicic L., Popovic P., Jandric D., Medic-Mijacevic L., and Rakic L. Modulatory effect of 7-thia-8-oxoguanosine on proliferation of rat thymocytes in vitro stimulated with concanavalin A. Int. J. Immunopharmacol. 22 (2000) 203-212
5. Dow S.W., Fradkin L.G., Liggitt D.H., Willson A.P., Heath T.D., and Potter T.A. Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously. J. Immunol. 163 (1999) 1552-1561
6. Durán N., and Nunes O.D.S. New polymer of proteic magnesium ammonium phospholinoleate anhydride from Penicillum sp (PB-73 Strain). Braz. J. Med. Biol. Res. 23 (1990) 1289-1302
7. Durán N., Haun M., Da Silva L.P., Pisani R., Nunes O.D.S., Souza-Brito A., and Mazetto M.N. Antiviral activity and toxicity of proteic magnesium ammonium phospholinoleate anhydride polymer from Penicillum sp. (PB-73 Strain) and its comparison with commercial antiviral drugs (ACYCLOVIR and IDOXURIDINE). Braz. J. Med. Biol. Res. 23 (1990) 1113-1303
8. Durán N., Haun M., Souza-Brito A.R.M., Vargas L., Justo J.Z., De Oliveira A., and Hetem A. SB-73. An immunostimulant. Drug Future 18 (1993) 327-334
9. Durán N., Justo G.Z., Queiroz M.L.S., Vieira-Matos A.N., and Rettori O. New perspective in immunomodulatory therapy of tumor induced by an extracellular aggregated polymer isolated from Aspergillus orizae. Int. J. Mol. Med. 4 Suppl. 1 (1999) S-49 280
10. Farmabrasilis, 2009a.P-MAPA toxicity and safety. Available from www.farmabrasilis.org.br/todos_conteudos_interna.php?idioma=eng&id=2 17.
11. Farmabrasilis, 2009b. P-MAPA clinical trial phase I. Available from www.farmabrasilis.org.br/interna_relatorios_clinicos.php?idioma=eng& id=180.
12. Fisher A.F., Tesh R.B., Tonry J., Guzman H., Liu D., and Xiao S.Y. Induction of severe disease in hamsters by two sandfly fever group viruses, Punta Toro and Gabek forest (phlebovirus, bunyaviridae), similar to that caused by rift valley fever virus. Am. J. Trop. Med. Hyg. 69 (2003) 269-276
13. Gabrielsen B., Monath T.P., Huggins J.W., Kefauver D.F., Pettit G.R., Groszek G., Hollingshead M., Kirsi J.J., Shannon W.M., Shubert E.M., Dare J., Ugarkar B., Ussery M.A., and Phelan M.J. Antiviral (RNA) activity of selected amaryllidaceae isoquinoline constituents and synthesis of related substances. J. Nat. Prod. 55 (1992) 1569-1581
14. Gowen B.B., Fairman J., Smee D.F., Wong M.H., Jung K.H., Pace A.M., Heiner M.L., Bailey K.W., Dow S.W., and Sidwell R.W. Protective immunity against acute phleboviral infection elicited through immunostimulatory cationic liposome-DNA complexes. Antiviral Res. 69 (2006) 165-172
15. Gowen B.B., Smee D.F., Wong M.H., Judge J.W., Jung K.H., Bailey K.W., Pace A.M., Rosenberg B., and Sidwell R.W. Recombinant Eimeria protozoan protein elicits resistance to acute phlebovirus infection in mice but not hamsters. Antimicrob. Agents Chemother. 50 (2006) 2023-2029
16. Gowen B.B., Wong M.H., Jung K.H., Sanders A.B., Mendenhall M., Bailey K.W., Furuta Y., and Sidwell R.W. In vitro and in vivo activities of T-705 against Arenavirus and Bunyavirus infections. Antimicrob. Agents Chemother. 51 (2007) 3168-3176
17. Gowen B.B., Wong M.H., Jung K.H., Sanders A.B., Mitchell W.M., Alexopoulou L., Flavell R.A., and Sidwell R.W. TLR3 is essential for the induction of protective immunity against Punta Toro virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not poly(I:C): differential recognition of synthetic dsRNA molecules. J. Immunol. 178 (2007) 5200-5208
18. Gowen B.B., Fairman J., Wong M.H., Jung K.H., Bailey K.W., and Morrey J.D. Prophylaxis with cationic liposome-DNA complexes protects hamsters from phleboviral disease: importance of CpG motifs?. FASEB J. 22 (2008) (Abstr) 859.18
19. Gowen B.B., Wong M.H., Jung K.H., Blatt L.M., and Sidwell R.W. Prophylactic and therapeutic intervention of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with interferon alfacon-1. Antiviral Res. 77 (2008) 215-224
20. Justo G.Z., Durán N., and Queiroz M.L.S. Effect on splenic T lymphocytes in Ehrlich ascites tumor bearing mice induced by MAPA-role of cytokines. Int. J. Mol. Med. 4 Suppl. 1 (1999) S-49 279
21. Justo G.Z., Durán N., and Queiroz M.L.S. Myelopoietic response in tumor-bearing mice by an aggregated polymer isolated from Aspergillus orizae. Eur. J. Phamacol. 388 (1999) 219-226
22. Justo G.Z., Durán N., and Queiroz M.L.S. Natural killer cell activity, lymphocyte proliferation and cytokines profile in tupour-bearing mice treated with MAPA, a magnesium aggregated polymer from Aspergillus orizae. Immunopharmacol. Immunotoxicol. 25 (2003) 305-319
23. Mead J.R., Burger R.A., Yonk L.J., Coombs J., Warren R.P., Kende M., Huggins J., and Sidwell R.W. Effect of human, recombinant interleukin 2 on Punta Toro virus infections in C57BL/6 mice. Antiviral Res. 15 (1991) 331-340
24. Melo A., Justo G.Z., and Queiroz M.L.S. Stimulation of myelopoiesis in Listeria monocytogenes-infected mice by an aggregated polymer isolated from Aspergillus oryzae. Human Exp. Toxicol. 20 (2001) 38-45
25. NCI-National Cancer Institute, 2007. Phase I/II study of 3-dimensional conformal radiotherapy, trans-hepatic arterial embolization followed by autologous tumor cell vaccine poly ICLC in patients with unresectable, recurrent, or metastatic primary hepatocellular or pancreatic cancer.
26. Neyts J., Meerbach A., McKenna P., and De Clercq E. Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections. Antiviral Res. 30 (1996) 125-132
27. Nunes, I., 2008. Building a new model for pharmaceuticals-P-MAPA, a novel immunomodulator against virus, bacterial, and protozoan infections. In: Abstracts of the International Conference on Drug Design and Discovery in Developing Countries; Trieste, Italy, July 3-5, 2008; Abstract I-8. International Centre for Science and High Technology (ICS), United Nations Industrial Development Organization (UNIDO). Accessed at www.ics.trieste.it/portal/ActivityDocument.aspx?id=5711.
28. Nunes, I.S., Justo, G.Z, Durán, N., 2004. Protein aggregate magnesium ammonium phospholinoleate palmitoleate anhydride immunomodulator, its production process and formulation. USA/PAT 10/978683.
29. Pifat D.Y., and Smith J.F. Punta Toro virus infection of c57bl/6j mice: a model for phlebovirus-induced disease. Microb. Pathog. 3 (1987) 409-422
30. Reed L.J., and Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27 (1938) 493-497
31. Romani L., Puccetti P., and Bistoni F. Interleukin-12 in infectious diseases. Clin. Microbiol. Rev. 10 (1997) 611-636
32. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14 (2001) 778-809
33. Santos M., Rodriguez S., Carballo N., Ruiz A., Vazquez G., Reyes E., and Alvarez-Mon M. Efficacy of treatment with AM3 (inmunoferon) in the prevention of proctitis in patients with prostate carcinoma treated with radiotherapy. J. Clin. Oncol. 22 14S (2004) 4741
34. Sellins K., Fradkin L., Liggitt D., and Dow S. Type I interferons potently suppress gene expression following gene delivery using liposome(-)DNA complexes. Mol. Ther. 12 (2005) 451-459
35. Sidwell R.W., Huffman J.H., Barnett B.B., and Pifat D.Y. In vitro and in vivo Phlebovirus inhibition by ribavirin. Antimicrob. Agents Chemother. 32 (1988) 331-336
36. Sidwell R.W., Huffman J.H., Barnard D.L., and Pifat D.Y. Effects of ribamidine, a 3-carboxamidine derivative of ribavirin, on experimentally induced phlebovirus infections. Antiviral Res. 10 (1988) 193-207
37. Sidwell R.W., Huffman J.H., Smee D.F., Gilbert J., Gessaman A., Pease A., Warren R.P., Huggins J., and Kende M. Potential role of immunomodulators for treatment of phlebovirus infections of animals. Ann. N. Y. Acad. Sci. 653 (1992) 344-355
38. Sidwell R.W., Huffman J.H., Barnard D.L., Smee D.F., Warren R.P., Chirigos M.A., Kende M., and Huggins J. Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections. Antiviral Res. 25 (1994) 105-122
39. Smee D.F., Huffman J.H., Hall L.L., Huggins J.W., and Sidwell R.W. Inhibition of phlebovirus infections in vivo by tiazofurin and selenazofurin. Antiviral Chem. Chemother. 1 (1990) 211-216
40. Smee D.F., Huffman J.H., Gessaman A.C., Huggins J.W., and Sidwell R.W. Prophylactic and therapeutic activities of 7-thia-8-oxoguanosine against Punta Toro virus infections in mice. Antiviral Res. 15 (1991) 229-239
41. Smee D.F., Coombs J., Huffman J.H., Huggins J.W., and Sidwell R.W. Combination chemotherapy of Punta Toro virus infections in mice using ribavirin and 7-thia-8-oxoguanosine. Antiviral Chem. Chemother. 2 (1991) 93-97
42. Smee D.F., Sidwell R.W., Huffman J.H., Huggins J.W., Kende M., and Verbiscar A.J. Antiviral activities of tragacanthin polysaccharides on Punta Toro virus infections in mice. Chemotherapy (Basel) 42 (1996) 286-293
43. Vroegop S.M., Chapman D.L., Galinet L.A., Decker D.E., Ready K.A., Brideau R.J., Dunn C.J., and Buxser S.E. Pharmacology of the biological response modifier bropirimine (PNU-54461) on experimental autoimmune encephalomyelitis (EAE) in mice. Int. J. Immunopharmacol. 21 (1999) 391-409